AFLD 2008 FFC vs Respondent M74

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M74 for a violation of the Anti-Doping Rules. During a cycling event on July 3 and 15, 2008, blood samples were taken for doping test purposes. The analysis of the samples showed the presence of a Erythropoietin (EPO) of the type Mircera which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent challenges the competence of the AFLD because the Tour de France wasn't mentioned as an event on the calender of the FCC. Secondly he had already received a sanction from the Austrian Anti-Doping Agency (NADA) on November 24, 2008, which was as period of ineligibility of two years.

Decision
1. The sanction is period of ineligibility of two years in which the respondent can't take part in competition or manifestations organized or authorized by French sport federations.
2. The period of ineligibility will be reduced by the period already served after October 13, 2008.
3. All the results obtained at the Tour de France 2008 are cancelled. Medals, points and prizes are withdrawn by the FCC.
4. The decision starts on the date of notification.
5. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
18 December 2008
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Competence / Jurisdiction
Ne bis in idem
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Nationale Anti-Doping Agentur Austria (NADA) - Austrian Anti-Doping Agency
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S2. Peptide Hormones, Growth Factors
Substances
Darbepoetin (dEPO)
Erythropoietin (EPO)
Methoxy polyethylene glycol-epoetin beta (CERA)
Document type
Pdf file
Date generated
14 July 2014
Date of last modification
16 October 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin